本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2006/1/191 分钟阅读
Able Laboratories, Inc.; Withdrawal of Approval of 43 Abbreviated New Drug Applications
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is withdrawing approval of 43 abbreviated new drug applications (ANDAs) held by Able Laboratories, Inc. (Able Labs), One Able Dr., Cranbury, NJ 08512. The drug products are no longer marketed, and Able Labs has requested that the approval of the applications be withdrawn.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →